iomeprol has been researched along with Vesicoureteral Reflux in 1 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Veldhoen, S | 1 |
| Sauer, A | 1 |
| Gassenmaier, T | 1 |
| Petritsch, B | 1 |
| Herz, S | 1 |
| Blanke, P | 1 |
| Derlin, T | 1 |
| Bley, TA | 1 |
| Wirth, C | 1 |
1 other study available for iomeprol and Vesicoureteral Reflux
| Article | Year |
|---|---|
Contrast-enhanced voiding urosonography phantom study: intravenous iodinated and gadolinium-based contrast agents may cause false-negative results in assessment of vesicoureteral reflux in children.
Topics: Administration, Intravesical; Contrast Media; False Negative Reactions; Humans; Injections, Intraven | 2015 |